3-表-25-羟基维生素D3

3-表-25-羟基维生素D3名称

[ 英文名 ]:
3-[2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol

[英文别名 ]:

(3s)-9,10-secocholesta-5,7,10-triene-3,25-diol
3-Epi-25-Hydroxyvitamin D3
25-Hydroxycholecalciferol
25-Hydroxy-vitamin D3

3-表-25-羟基维生素D3物理化学性质

[ 分子式 ]:
C₂₇H₄₄O₂

[ 分子量 ]:
400.63700

[ 精确质量 ]:
400.33400

[ PSA ]:
40.46000

[ LogP ]:
6.73390

3-表-25-羟基维生素D3MSDS

详细MSDS(安全技术说明书)

3-表-25-羟基维生素D3安全信息

[ 符号 ]:

GHS02, GHS07

[ 信号词 ]:
Danger

[ 危害声明 ]:
H225-H319

[ 警示性声明 ]:
P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235

[ 危险品运输编码 ]:
UN1170 - class 3 - PG 2 - Ethanol, solution

3-表-25-羟基维生素D3文献

Dietary resistant starch prevents urinary excretion of 25-hydroxycholecalciferol and vitamin D-binding protein in type 1 diabetic rats.

J. Nutr. 143(7) , 1123-8, (2013)

Diabetes is a rapidly growing epidemic affecting millions of Americans and has been implicated in a number of devastating secondary complications. We previously demonstrated that type 2 diabetic rats ...

25-hydroxvitamin D3 promotes the long-term effect of specific immunotherapy in a murine allergy model.

J. Immunol. 193(3) , 1017-23, (2014)

Calcitriol (1α,25-dihydroxyvitamin D3) is the active vitamin D metabolite and mediates immunological functions, which are relevant in allergy. Its therapeutic use is limited by hypercalcaemic toxicity...

Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab.

J. Clin. Oncol. 32(29) , 3242-8, (2014)

To investigate the impact and mechanisms of vitamin D deficiency (VDD) on the outcome of elderly patients with diffuse large B-cell lymphoma (DLBCL).Three hundred fifty-nine pretreatment 25-hydroxyvit...

更多文献